Form 4 for AXSM Axsome Therapeutics, Inc.
Accepted 2024-04-01 00:00:00 ET · period of report 2024-04-01 · accession 0000950170-24-039617 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2024-04-01 | 2024-04-01 | AXSM | Jacobson Mark L. | COO | M - OptEx | $1.30 | +24.7K | 24.7K | New | +$32.1K |
| DT | 2024-04-01 | 2024-04-01 | AXSM | Jacobson Mark L. | COO | S - Sale+OE | $77.24 | -24.7K | 0 | -100% | -$1.90M |
| DT | 2024-04-01 | 2024-04-01 | AXSM | Jacobson Mark L. | COO | M - OptEx | $0.00 | -24.7K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-04-01 | M | A | 24,662 | $1.30 | 24,662 | D | — | — | |
| 2 | Common | Common Stock | 2024-04-01 | S | D | 24,662 | $77.24 | 0 | D | — | — | |
| 3 | Derivative | Stock Option (Right to Buy) | 2024-04-01 | M | D | 24,662 | $0.00 | 0 | D | $1.30 · 2014-10-03 to 2024-04-03 | 24,662 Common Stock |